531210
COLINZ
Invest Now

Colinz Laboratories Share Price
₹80.46 +3.83 (5%)
24 Mar, 2025 12:26
Start SIP in
COLINZ
Performance
- Low
- ₹80
- High
- ₹80
- 52 Week Low
- ₹36
- 52 Week High
- ₹84
- Open Price₹80
- Previous Close₹77
- Volume2,063
Investment Returns
- Over 1 Month + 88.7%
- Over 3 Month + 16.61%
- Over 6 Month + 34.1%
- Over 1 Year + 107.32%
Smart Investing Starts Here Start SIP with Colinz Laboratories for Steady Growth!
Colinz Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42
- PEG Ratio
- 55.8
- Market Cap Cr
- 20
- P/B Ratio
- 2.3
- Average True Range
- 3.21
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.98
- RSI
- 82.72
- MFI
- 94.65
Colinz Laboratories Financials
Colinz Laboratories Technicals
EMA & SMA
Current Price
₹80.46
+
3.83
(5%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹58.56
- 50 Day
- ₹56.32
- 100 Day
- ₹56.92
- 200 Day
- ₹55.56
Resistance and Support
76.63
- R3 76.63
- R2 76.63
- R1 76.63
- S1 76.63
- S2 76.63
- S3 76.63
Colinz Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-31 | Quarterly Results | |
2024-10-30 | Quarterly Results | |
2024-08-08 | Others | Inter-alia, 1. To Consider and approve the Director's Report for the year ended 31st March, 2024. 2. To Consider and approve the Management Discussion Report, Corporate Governance Report. |
2024-07-31 | Quarterly Results | |
2024-05-29 | Quarterly Results |
Colinz Laboratories F&O
About Colinz Laboratories
- NSE Symbol
- COLINZ
- BSE Symbol
- 531210
- ISIN
- INE923C01011
Similar Stocks to Colinz Laboratories
Colinz Laboratories FAQs
Colinz Laboratories share price is ₹80 As on 24 March, 2025 | 12:12
The Market Cap of Colinz Laboratories is ₹20.3 Cr As on 24 March, 2025 | 12:12
The P/E ratio of Colinz Laboratories is 42 As on 24 March, 2025 | 12:12
The PB ratio of Colinz Laboratories is 2.3 As on 24 March, 2025 | 12:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.